Mount Sinai launches combination therapy trial to treat relapsing-remitting Multiple Sclerosis
Mount Sinai launches combination therapy trial to treat relapsing-remitting Multiple Sclerosis
EurekAlert! Tue, 11 Apr 2006 7:36 AM PDT
New York, NY - Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis.
Epstein-Barr Virus May Trigger MS
WebMD Mon, 10 Apr 2006 1:48 PM PDT
Young adults with high levels of antibodies to Epstein-Barr virus appear to be at increased risk for developing multiple sclerosis later in life, new research suggests.
EurekAlert! Tue, 11 Apr 2006 7:36 AM PDT
New York, NY - Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis.
Epstein-Barr Virus Could Boost Multiple Sclerosis Risk HealthDay via Yahoo! News Mon, 10 Apr 2006 1:02 PM PDT MONDAY, April 10 (HealthDay News) -- Exposure to the Epstein-Barr virus, which often causes mononucleosis in young adults, may double the risk of developing multiple sclerosis (MS) 15 to 20 years later, researchers report. |
Study links common virus to multiple sclerosis Reuters via Yahoo! News Mon, 10 Apr 2006 1:44 PM PDT Young adults whose immune systems react strongly when exposed to a common virus may run a higher risk of developing multiple sclerosis later in life, researchers reported on Monday. |
Virus tied to multiple sclerosis in long-term study Reuters via Yahoo! News Mon, 10 Apr 2006 2:33 PM PDT Elevated blood levels of antibodies to Epstein-Barr virus (EBV) can be seen in multiple sclerosis (MS) patients decades before the onset of disease, according to a report published today. |
Epstein-Barr virus infection linked to multiple sclerosis News-Medical-Net Tue, 11 Apr 2006 2:03 AM PDT Young adults with high levels of antibodies against the Epstein-Barr virus, the virus that most often causes mononucleosis, may be more likely to develop multiple sclerosis 15 to 20 years later, according to a study in the Archives of Neurology. |
Virus linked to multiple sclerosis Aljazeera Mon, 10 Apr 2006 7:02 PM PDT Young adults, whose immune systems react strongly when exposed to a common virus, may run a higher risk of developing multiple sclerosis (MS) later in life, a new report has revealed. |
Epstein-Barr Linked to Multiple Sclerosis RedNova Mon, 10 Apr 2006 6:08 PM PDT Young adults with high levels of antibodies against the Epstein-Barr virus may be more likely to develop multiple sclerosis, says a U.S. study. |
Epstein-Barr Virus May Be Associated with Multiple Sclerosis Newswise Mon, 10 Apr 2006 1:25 PM PDT Young adults with high levels of antibodies against the Epstein-Barr virus, the virus that most often causes mononucleosis, may be more likely to develop multiple sclerosis 15 to 20 years later, according to a study posted online today that will appear in the June 2006 print issue of Archives of Neurology. |
Epstein-Barr Virus Could Boost Multiple Sclerosis Risk Health Scout Mon, 10 Apr 2006 2:05 PM PDT A vaccine against the virus might also help prevent MS, experts say. |
Epstein-Barr Virus May Trigger MS
WebMD Mon, 10 Apr 2006 1:48 PM PDT
Young adults with high levels of antibodies to Epstein-Barr virus appear to be at increased risk for developing multiple sclerosis later in life, new research suggests.
0 Comments:
Post a Comment
<< Home